Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04943627
Title Balstilimab in Patients With Recurrent Cervical Cancer.
Recruitment Withdrawn
Gender female
Phase Phase III
Variant Requirements No
Sponsors Agenus Inc.
Indications

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma

Therapies

Topotecan

Balstilimab

Gemcitabine

Irinotecan

Pemetrexed Disodium

Vinorelbine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.